Hoth Therapeutics Stock Return On Equity
HOTH Stock | USD 1.20 0.02 1.69% |
Hoth Therapeutics fundamentals help investors to digest information that contributes to Hoth Therapeutics' financial success or failures. It also enables traders to predict the movement of Hoth Stock. The fundamental analysis module provides a way to measure Hoth Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hoth Therapeutics stock.
Last Reported | Projected for Next Year | ||
Return On Equity | (0.89) | (0.93) |
Hoth | Return On Equity |
Hoth Therapeutics Company Return On Equity Analysis
Hoth Therapeutics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Hoth Therapeutics Return On Equity | -1.13 |
Most of Hoth Therapeutics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hoth Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Hoth Return On Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for Hoth Therapeutics is extremely important. It helps to project a fair market value of Hoth Stock properly, considering its historical fundamentals such as Return On Equity. Since Hoth Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Hoth Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Hoth Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition |
Hoth Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Hoth Therapeutics has a Return On Equity of -1.1258. This is 95.3% lower than that of the Pharmaceuticals sector and 96.91% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Hoth Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hoth Therapeutics' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hoth Therapeutics could also be used in its relative valuation, which is a method of valuing Hoth Therapeutics by comparing valuation metrics of similar companies.Hoth Therapeutics is currently under evaluation in return on equity category among related companies.
Hoth Therapeutics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Hoth Therapeutics from analyzing Hoth Therapeutics' financial statements. These drivers represent accounts that assess Hoth Therapeutics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Hoth Therapeutics' important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 56.7M | 29.3M | 14.7M | 9.3M | 4.9M | 4.7M | |
Enterprise Value | 55.0M | 26.7M | 6.2M | 2.9M | (4.3M) | (4.1M) |
Hoth Fundamentals
Return On Equity | -1.13 | ||||
Return On Asset | -0.59 | ||||
Current Valuation | (3.97 M) | ||||
Shares Outstanding | 4.89 M | ||||
Shares Owned By Insiders | 1.62 % | ||||
Shares Owned By Institutions | 6.97 % | ||||
Number Of Shares Shorted | 218.06 K | ||||
Price To Earning | (7.16) X | ||||
Price To Book | 0.68 X | ||||
EBITDA | (7.69 M) | ||||
Net Income | (7.85 M) | ||||
Cash And Equivalents | 11.62 M | ||||
Cash Per Share | 9.02 X | ||||
Total Debt | 55.16 K | ||||
Debt To Equity | 2.01 % | ||||
Current Ratio | 15.74 X | ||||
Book Value Per Share | 2.03 X | ||||
Cash Flow From Operations | (8.45 M) | ||||
Short Ratio | 0.19 X | ||||
Earnings Per Share | (2.30) X | ||||
Target Price | 4.67 | ||||
Beta | 0.61 | ||||
Market Capitalization | 5.84 M | ||||
Total Asset | 9.52 M | ||||
Retained Earnings | (52.94 M) | ||||
Working Capital | 8.75 M | ||||
Current Asset | 448.84 K | ||||
Current Liabilities | 312.22 K | ||||
Net Asset | 9.52 M |
About Hoth Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hoth Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hoth Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hoth Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Hoth Therapeutics Piotroski F Score and Hoth Therapeutics Altman Z Score analysis. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Complementary Tools for Hoth Stock analysis
When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Equity Valuation Check real value of public entities based on technical and fundamental data |
Is Hoth Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hoth Therapeutics. If investors know Hoth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.30) | Return On Assets (0.59) | Return On Equity (1.13) |
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.